Investment Readiness Report
The full multi-agent analysis — score, strengths, risks, valuation benchmarks and a partner-grade memo. Re-run it any time your company changes.
Apex Synthesis is the operating system for the eighteen months around your round. It tells you what's weak, what to fix first, what it's worth once fixed, and who to show it to — then keeps score while you do the work.
Works pre-revenue · Your data is never used for training
Not a set of disconnected tools. One workspace that knows your company and gets sharper the longer you use it.
The full multi-agent analysis — score, strengths, risks, valuation benchmarks and a partner-grade memo. Re-run it any time your company changes.
Trained on venture frameworks and your actual company data. Ask it why slide 6 isn't landing, what your bridge should look like, or how to answer a term you don't like.
Sit a mock partner meeting or a diligence grilling. Choose the archetype — the sceptical operator, the metrics partner, the thesis-driven generalist.
A ranked list of what to prove next, each with an estimated score impact — so you spend the next eight weeks on the thing that actually matters.
Funds ranked by genuine thesis fit, stage, cheque size, geography and how recently they actually deployed — not a scraped list of everyone with "Ventures" in the name.
One-pagers, executive summaries, data room checklists and monthly investor updates, generated from live company data rather than last quarter's copy-paste.
The questions that kill rounds are rarely the ones on your rehearsal list. Run a simulated partner meeting and find out which answer you don't have — while it still costs you nothing.
Partner: Your deck says net retention is 118%. Is that logo or dollar, and does it include the two accounts you upsold in December?
You: Dollar-based, and yes it includes them.
Partner: Then strip them out and tell me the number. I want to know what happens in a quarter where nothing unusual occurs.
— transcript continues —
Weak point: you conceded the framing instead of pre-empting it. Lead with the ex-upsell figure (109%) and you own the number rather than defending it.
First report. Score of 61, Tier C. Three material risks named: concentration, CAC payback, and a TAM slide that won't survive contact.
Work the top three milestones. Restate market sizing bottom-up. Pricing tier introduced to shorten payback. Deck rewritten section by section with the mentor.
Score moves to 71. Market dimension goes from the weakest to the second strongest. Two risks downgraded, one closed.
Two design partners land in a second vertical. Concentration falls below 30%. Mock meetings run weekly against different archetypes.
Score at 78, Tier B+. Investor shortlist generated: 23 funds ranked by thesis fit. Warm-path analysis identifies eleven routes in.
Conversations start with the objections already answered. The readiness snapshot goes out with the deck instead of after the third call.
I'd been told my deck was great by fifteen people who weren't going to invest. The first Apex Synthesis report was the first honest read I got.
The mock meetings were brutal in exactly the right way. By the time I sat in front of a real partner, I'd already been asked every hard question twice.
We were about to raise six months too early. The score said so, we listened, and we raised at nearly double the valuation instead.
Yes — arguably more so. Pre-seed companies are scored on founder–market fit, evidence of the problem, speed of learning and clarity of the wedge. You'll get a readiness path and a realistic answer to "should we be raising now or in five months", which is the most expensive question at your stage.
It will rewrite sections with you, slide by slide, and tell you why each change matters to a reader who has eleven minutes. It won't hand you a finished deck — a deck that sounds like nobody wrote it is its own kind of red flag.
Monthly is typical, or whenever something material changes — a big customer, a key hire, a pricing change, a new competitor round. The score recalculates continuously from connected data; a full agent re-run is what refreshes the memo and the risk ranking.
Growth plans include five seats with role-based access. You can scope a seat so an advisor sees the report but not the cap table, or so a new hire sees the milestone roadmap only.
Challenge it. Every dimension shows its inputs and weighting, and you can dispute any finding with counter-evidence — the agents re-evaluate against what you provide. Several of our best-scoring companies argued their way up by supplying data the deck never mentioned.
Four minutes and a deck. Find out where you actually stand before you spend five months finding out the slow way.